chr7-45574760-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_021116.4(ADCY1):c.217G>A(p.Gly73Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000083 in 1,434,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000060 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000086 ( 0 hom. )
Consequence
ADCY1
NM_021116.4 missense
NM_021116.4 missense
Scores
1
2
15
Clinical Significance
Conservation
PhyloP100: 3.79
Genes affected
ADCY1 (HGNC:232): (adenylate cyclase 1) This gene encodes a member of the of adenylate cyclase gene family that is primarily expressed in the brain. This protein is regulated by calcium/calmodulin concentration and may be involved in brain development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ADCY1. . Gene score misZ 4.3801 (greater than the threshold 3.09). Trascript score misZ 4.6991 (greater than threshold 3.09). GenCC has associacion of gene with hearing loss, autosomal recessive, autosomal recessive nonsyndromic hearing loss 44.
BP4
Computational evidence support a benign effect (MetaRNN=0.13701522).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADCY1 | NM_021116.4 | c.217G>A | p.Gly73Ser | missense_variant | 1/20 | ENST00000297323.12 | NP_066939.1 | |
ADCY1 | XM_005249584.4 | c.217G>A | p.Gly73Ser | missense_variant | 1/19 | XP_005249641.1 | ||
ADCY1 | XM_005249585.3 | c.217G>A | p.Gly73Ser | missense_variant | 1/9 | XP_005249642.1 | ||
ADCY1 | NM_001281768.2 | c.-330-129G>A | intron_variant | NP_001268697.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADCY1 | ENST00000297323.12 | c.217G>A | p.Gly73Ser | missense_variant | 1/20 | 1 | NM_021116.4 | ENSP00000297323 | P1 | |
ADCY1 | ENST00000432715.5 | c.-330-129G>A | intron_variant | 2 | ENSP00000392721 |
Frequencies
GnomAD3 genomes AF: 0.0000668 AC: 10AN: 149658Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
149658
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000235 AC: 1AN: 42500Hom.: 0 AF XY: 0.0000401 AC XY: 1AN XY: 24946
GnomAD3 exomes
AF:
AC:
1
AN:
42500
Hom.:
AF XY:
AC XY:
1
AN XY:
24946
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000856 AC: 110AN: 1284454Hom.: 0 Cov.: 30 AF XY: 0.0000855 AC XY: 54AN XY: 631558
GnomAD4 exome
AF:
AC:
110
AN:
1284454
Hom.:
Cov.:
30
AF XY:
AC XY:
54
AN XY:
631558
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000601 AC: 9AN: 149750Hom.: 0 Cov.: 32 AF XY: 0.0000684 AC XY: 5AN XY: 73070
GnomAD4 genome
AF:
AC:
9
AN:
149750
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
73070
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 15, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ADCY1 protein function. This variant has not been reported in the literature in individuals affected with ADCY1-related conditions. This variant is present in population databases (rs544024276, gnomAD 0.01%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 73 of the ADCY1 protein (p.Gly73Ser). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of glycosylation at G73 (P = 0.0755);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at